Abstract
7α,12α-Dihydroxy-3-oxo- and 3,7,12-trioxo-5β-cholanoic acids labeled with 18O atoms were incubated with human red blood cells, and the biotransformation products were separated and characterized by gas chromatography-mass spectrometry as the pentafluorobenzyl ester-trimethylsilyl and -dimethylethylsilyl ether derivatives with the negative ion chemical ionization mode. The reduced products, 3β,7α,12α-trihydroxy-5β-cholanoic acid for the former, and 3α-hydroxylated dioxo bile acid together with 3β-hydroxylated 7,12-dioxo-5β-cholanoic acid for the latter, were identified as metabolites. When 3-oxo bile acid was incubated with human blood denatured at 70°C for 2 min, no metabolites were formed. The enzymic reduction activity has been localized in the red blood cell fraction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
